EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›WOOF

WOOF

Petco Health & Wellness Company, Inc.

Next earnings Aug 26, 2026 · consensus $0.07 EPS, $1.52B rev

Last earnings +3.0% on 2026-06-03

Hold
$2.62
▼ -4.73%
$2.62▼ -6.09%
over 1Y
L $2.33EODHDH $4.36
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-4.7%
1W+1.9%
1M-11.5%
3M-2.2%
YTD-8.1%
1Y-6.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C-
Valuation
Overvalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 17 analysts
Buy

Busted-IPO retailer priced at 0.1x sales with a real cash-flow turnaround — but shrinking revenue and heavy debt cap the upside.

Revenue $5.96B · FY2026

The read

Middling fundamentals and a rich price (~63% above fair value) leave little margin of safety — a wait-and-see.

Petco is a leveraged turnaround, not a growth story. Revenue has declined three straight years ($6.26B FY2024 → $6.12B FY2026… → $5.96B FY2026, -2.5% YoY), which is the core problem: this is a low-margin specialty retailer being squeezed between Chewy/Amazon online and Walmart/Costco on price, and the MD&A offers no revenue catalyst — it leans on 'comparable sales' and a membership push while flagging tariffs, inflation and supply-chain pressure it 'cannot predict.' On the flip side, the operating turnaround is genuine: operating income swung to $120M from near-zero (+1,608%), the company clawed back to a $9.07M net profit after a -$1.28B FY2024 and -$102M FY2025, and operating cash flow jumped 77% to $314M against $127M capex — roughly ~$187M of free cash flow versus a $732M market cap. Cash grew 55% to $257M while long-term debt fell to $1.49B.

Valuation is where it gets interesting. At $2.62 the equity trades at 0.1x sales, and on an enterprise basis (~$1.96B EV vs. ~$317M EBITDA using $120M operating income + $197M D&A) it's near ~6x EV/EBITDA — cheap, not distressed. The 87x P/E is a meaningless artifact of a $0.03 EPS. So a lot of pessimism is already priced in, and the FCF supports continued deleveraging, which is the single most important lever for a stock this levered.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$5.81B$6.04B$6.26B$6.12B$5.96B
Gross profit$2.43B$2.43B$2.35B$2.32B$2.31B
Operating income$266M$226M-$1.18B$7.05M$120M
Net income$164M$90.8M-$1.28B-$102M$9.07M
Diluted EPS$0.62$0.34-$4.78-$0.37$0.03
Net margin2.8%1.5%-20.5%-1.7%0.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.01B
EV / EBITDA6.3
EV / Sales0.3
EV / FCF10.7
P / FCF4.2
PEG (trailing)0.80
Earnings yield1.2%
FCF yield24.1%

Quality & risk

ROIC (est.)3.6%
Free cash flow$187M
Total debt$1.49B
Net cash-$1.23B
Altman Z-Score1.01 distress
Piotroski F-Score7/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+2.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Officer / director change2026-07-01

    Annual meeting vote results plus a board/officer change disclosed

  2. 10-Q Quarterly report2026-06-05

    Q1 FY27 quarterly report filed (period ended May 2)

  3. 8-K Earnings results2026-06-03

    Released Q1 FY27 earnings for quarter ended May 2

  4. DEF 14A Proxy statement2026-05-14

    Proxy: director elections, say-on-pay, executive compensation

  5. 10-K Annual report2026-03-13

    FY26 10-K: back to profit ($9M), op income +16x, cash +55%, debt cut

  6. 8-K Earnings results2026-03-11

    FY26 results: revenue $5.96B, returned to net profit vs prior-year loss

  7. 8-K Officer / director change2026-02-02

    Entered new financing agreement/debt obligation (facility amendment)

  8. 8-K Material agreement2026-02-02

    Entered new financing agreement/debt obligation (facility amendment)

  9. 8-K Reg FD disclosure2026-01-23

    Reg FD business/investor update disclosed

Recent filings

all on EDGAR ↗
4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗8-KPeriod ending 2026-06-302026-07-01open ↗10-QPeriod ending 2026-05-022026-06-05open ↗8-KPeriod ending 2026-06-032026-06-03open ↗4Period ending 2026-05-182026-05-20open ↗ARSPeriod ending 2026-01-312026-05-14open ↗DEFA14AFiling2026-05-14open ↗DEF 14APeriod ending 2026-06-302026-05-14open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueC
GrowthB-
ProfitabilityD
Financial healthB-
MomentumF
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$0.96

Overvalued -63% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.03 × (8.5 + 1.5 × 22.0% growth) × 0.77 quality = 31.9× multiple. An estimate, not a price target.

2.3352-week4.36
Revenue
$5.96B
-2.5% YoY
Net margin
0.2%
ROE
0.8%
P/E
87.3

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$5.96B-2.5%
Net income$9.07M+108.9%
Gross profit$2.31B-0.8%
Operating income$120M+1608.0%
Diluted EPS$0.03+108.1%
Cash & equivalents$257M+54.9%
Total assets$5.17B-0.4%
Total liabilities$4.01B-1.8%
Stockholders' equity$1.16B+4.5%
Gross: 38.7%Op.: 2.0%L/E: 3.44x

Frequently asked

Is Petco Health & Wellness Company, Inc. (WOOF) a buy?
WOOF currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Busted-IPO retailer priced at 0.1x sales with a real cash-flow turnaround — but shrinking revenue and heavy debt cap the upside.
What is WOOF's fair value?
A Modified-Graham model based on WOOF's SEC fundamentals estimates a fair value of about $0.96. It is an estimate from reported earnings, not a price target.
Is WOOF overvalued or undervalued?
Against a Modified-Graham fair-value estimate, WOOF currently appears overvalued relative to its SEC-grounded earnings power.
What is Petco Health & Wellness Company, Inc.'s quality score?
WOOF scores 53.00757575757576/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001826470, latest 10-Q filed 2026-06-05) · EODHD · Proprietary analysis · as of 7/3/2026, 3:28:58 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-30
Murphy Glenn
Director
Award60.7K
2026-06-30
BRIGGS GARY S
Director
Award60.7K
2026-06-30
Yen Iris
Director
Award60.7K
2026-06-30
Breitner Cameron
Director
Award60.7K
2026-06-30
MOHAN RAJENDRA M
Director
Award60.7K
2026-05-18
Venezia Patrick J
Chief Revenue Officer
Tax26.1K @ $2.50$65.3K
2026-05-01
Anderson Joel D
Chief Executive Officer
Award2.86K @ $2.45$7.01K
2026-04-15
Insana Giovanni
See Remarks
Tax22.3K @ $2.80$62.5K

Earnings history

beat/miss · move
2026-06-03Beat +65.3% est▲ +3.04%8-K ↗
2026-03-11Beat +206.1% est▲ +3.00%8-K ↗
2025-11-25Beat +420.2% est▲ +6.45%8-K ↗
2025-08-28—▲ +0.94%8-K ↗
2025-06-05—▲ +1.69%8-K ↗
2025-03-26—▼ -1.21%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
3 Consumer Stocks That Concern UsBullish
finance.yahoo.com· 2026-06-26
Petco pulls back on what Amazon and Chewy can't matchBullish
finance.yahoo.com· 2026-06-24
Citi Maintains Buy Rating for Chewy Inc. (CHWY)Bullish
finance.yahoo.com· 2026-06-23
Chewy's Modern Animal Acquisition Strengthens Pet Healthcare PlatformBullish
finance.yahoo.com· 2026-06-22
Chewy Stock Tumbles 45% in 3 Months: What Should Investors Do Now?Bullish
finance.yahoo.com· 2026-06-18
Is CHWY Stock a Buy After Its Selloff and Lower Revenue ViewBullish
finance.yahoo.com· 2026-06-17

Vs tracked universe

compare →

1196 tracked peers · median

EDGAR Score53 vs 67
Revenue growth-2.5% vs 7.5%
Net margin0.2% vs 10.0%
Return on equity0.8% vs 11.9%
P/E87.3 vs 26.3

News sentiment

EODHD · 27d
Bullish
+0.17
vs typical · 45 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.